Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Remsima - Google News
Get the latest updates from Remsima - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 8 months ago
Celltrion applies for Australian approval for Stelara biosimilar - KBR
8 months ago
Celltrion applies for Australian approval for Stelara biosimilar KBR
Infliximab Biosimilar Market 2023 Top Trends with Insights on Key ... - The Knox Student
8 months ago
Infliximab Biosimilar Market 2023 Top Trends with Insights on Key ... The...
Market Insights into the Protein Inhibitors Industry: Comprehensive ... - Digital Journal
8 months ago
Market Insights into the Protein Inhibitors Industry: Comprehensive ... Digital Journal
Celltrion Healthcare Co., Ltd. authorizes a Buyback Plan. - Marketscreener.com
8 months ago
Celltrion Healthcare Co., Ltd. authorizes a Buyback Plan. Marketscreener.com
Celltrion expects 50% jump in 2024 sales after merger - The Investor
8 months ago
Celltrion expects 50% jump in 2024 sales after merger The Investor
Celltrion expects 50% jump in 2024 sales after merger - The Korea Herald
8 months ago
Celltrion expects 50% jump in 2024 sales after merger The Korea Herald
Celltrion expects 50% jump in 2024 sales after merger - The Korea Herald
8 months ago
Celltrion expects 50% jump in 2024 sales after merger The Korea Herald
Celltrion to release Stelara biosimilar in US from March 2025 - Korea Economic Daily
8 months ago
Celltrion to release Stelara biosimilar in US from March 2025 Korea Economic...
Celltrion completes license deal with J&J to sell autoimmune ... - Yonhap News Agency
8 months ago
Celltrion completes license deal with J&J to sell autoimmune ... Yonhap News...
Celltrion completes U.S. patent settlement with J&J, eyeing Stelara ... - KBR
8 months ago
Celltrion completes U.S. patent settlement with J&J, eyeing Stelara ... KBR
Celltrion completes U.S. patent settlement with J&J, eyeing Stelara biosimilar launch in March 2025 - KBR
8 months ago
Celltrion completes U.S. patent settlement with J&J, eyeing Stelara biosimilar launch in...
More than 10 US insurers list Celltrion's Avastin biosimilar on ... - KBR
9 months ago
More than 10 US insurers list Celltrion's Avastin biosimilar on ... KBR